Overview of cancer for the healthcare team: Aetiopathogenesis and early diagnosis

Oral Oncology

Volumn 46, Issue 6, 2010, Pages 402-406

  Scully, Crispian ^a   Petti, Stefano ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aetiology; Alcohol; Betel; Cancer; Diagnosis; Tobacco

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; BETEL NUT; CANCER RISK; CARCINOGENESIS; EARLY DIAGNOSIS; GENE MUTATION; GENETIC PREDISPOSITION; HEALTH PROMOTION; HUMAN; LIFESTYLE; MOUTH CANCER; ONCOGENE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MOUTH NEOPLASMS; NEOPLASM STAGING; PATIENT CARE TEAM; PROGNOSIS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 77952744240     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.02.026     Document Type: Review

References (43)

1. Scully C., and Moles D. Oral cancer in "Encyclopedia of Public Health" (2008), Elsevier, Edinburgh
2. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 (2000) 256-263
3. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36 (2000) 311-327
4. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinic-pathological applications. Oral Oncol 36 (2000) 404-413
5. Petti S. Lifestyle risk factors for oral cancer. Oral Oncol 2009 April-May;45(4-5):340-350 [Epub 2008 July 31].
6. Brunnemann K.D., Prokopczyk B., Djordjevic M.V., et al. Formation and analysis of tobacco-specific N-nitrosamines. Crit Rev Toxicol 26 (1996) 121-137
7. Hoffmann D., and Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 50 (1997) 307-364
8. Cogliano V., Straif K., Baan R., et al. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol 5 (2004) 708
9. IARC. Betel-quid and Areca-nut chewing and some Areca-nut-derived nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 85. Lyon: IARC; 2004.
10. Sawair F.A., Al-Mutwakel A., Al-Eryani K., et al. High relative frequency of oral squamous cell carcinoma in Yemen: qat and tobacco chewing as its aetiological background. Int J Environ Health Res 17 (2007) 185-195
11. Fasanmade A., Kwok E., and Newman L. Oral squamous cell carcinoma associated with khat chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) e53-e55
12. Hashibe M., Straif K., Tashkin D.P., et al. Epidemiologic review of marijuana use and cancer risk. Alcohol 35 (2005) 265-275
13. Seitz H.K., and Cho C.H. Contribution of alcohol and tobacco use in gastrointestinal cancer development. Method Mol Biol 472 (2009) 217-241
14. Roepman P., Wessels L.F., Kettelarij N., et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37 (2005) 182-186
15. Lippman S.M., and Hong W.K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17 (1989) 691-694
16. Scully C. Medical problems in dentistry. 4th ed. Oxford, Edinburgh, London: Elsevier; 2010.
17. Petti S., and Scully C. Alcohol and oral health. In: Wilson M. (Ed). Food constituents and oral health: current status and future prospects (2009), Woodhead Publishing Ltd., Cambridge 350-380
18. Ernst E. Harmless herbs? A review of the recent literature. Amer J Med 104 (1998) 170-178
19. Boucher B.J., and Mannan N. Metabolic effects of the consumption of Areca catechu. Addict Biol 1 (2002 January) 103-110
20. Tominaga S. Major avoidable risk factors of cancer. Cancer Lett 143 Suppl 1 (1999) S19-S23
21. .
22. Boyle P., Autier P., Bartelink H., Boffetta B.J., Burn J., Burns H.J.G., et al. European code against cancer and scientific justification: third version. Annal Oncol 14 (2003) 973-1005
23. Scully C., Boyle P., Day T., Hill B., Joshi V., Leupold N.E., et al. International consortium on head and neck cancer awareness (ICOHANCA). Oral Oncol 43 (2007) 841-842
24. Califano J., Westra W.H., Meininger G., et al. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6 (2000) 347-352
25. Braakhuis B.J., Leemans C.R., and Brakenhoff R.H. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33 (2004) 317-322
26. Braakhuis B.J., Leemans C.R., and Brakenhoff R.H. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 15 (2005) 113-120
27. Braakhuis B.J., Brakenhoff R.H., and Leemans C.R. Head and neck cancer: molecular carcinogenesis. Annal Oncol 16 Suppl 2 (2005) ii249-ii250
28. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., et al. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 10 (2004) 3607-3613
29. 2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori 72 (1986) 307-312
30. Holmstrup P., Vedtofte P., Reibel J., et al. Oral premalignant lesions: is a biopsy reliable?. J Oral Pathol Med 36 (2007) 262-266
31. Abbey L.M., Kaugars G.E., Gunsolley J.C., Burns J.C., Page D.G., Svirsky J.A., et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80 (1995) 188-191
32. Karabulut A., Reibel J., Therkildsen M.H., Praetorius F., Nielsen H.W., and Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24 (1995) 198-200
33. Fischer D.J., Epstein J.B., Morton Jr. T.H., and Schwartz S.M. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol 41 (2005) 489-496 [Epub 2005 March 16]
34. Brennan J.A., Mao L., Hruban R.H., et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332 (1995) 429-435
35. Bilde A., von Buchwald C., Dabelsteen E., et al. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med 38 (2009) 72-78
36. Cortesina G., Martone T., Galeazzi E., et al. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer 89 (2000) 286-292
37. Santhi W.S., Sebastian P., Varghese B.T., et al. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol 81 (2006) 123-130
38. Shaw R.J., Hall G.L., Woolgar J.A., et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 45 (2007) 617-622
39. Shaw R.J., Liloglou T., Rogers S.N., et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94 (2006) 561-568
40. Ball V.A., Righi P.D., Tejada E., et al. P53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J 76 (1997) 818-823
41. Tjebbes G.W., Leppers vd Straat F.G., Tilanus M.G., et al. P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol 35 (1999) 384-389
42. Lee J.J., Hong W.K., Hittelman W.N., et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6 (2000) 1702-1710
43. Scully C., Sudbø J., and Speight P.M. Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 32 (2003) 251-256